{"id":972125,"date":"2026-06-15T11:07:06","date_gmt":"2026-06-15T15:07:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/"},"modified":"2026-06-15T11:07:06","modified_gmt":"2026-06-15T15:07:06","slug":"wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/","title":{"rendered":"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SAN DIEGO<\/span>, June 15, 2026<\/span> \/PRNewswire\/ —\u00a0Robbins Geller Rudman & Dowd LLP<\/b><\/a> announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the “Class Period”), have until August 3, 2026 to seek appointment as lead plaintiff of the GeneDx <\/i>class action lawsuit.\u00a0 Captioned Basma v. GeneDx Holdings Corp.<\/i>, No. 26-cv-00880 (D. Conn.), the GeneDx <\/i>class action lawsuit charges GeneDx as well as certain of GeneDx’s top executive officers with violations of the Securities Exchange Act of 1934.<\/p>\n

\n

\n \"Robbins\n <\/p>\n<\/p><\/div>\n

\n If you suffered substantial losses and wish to serve as lead plaintiff of the <\/b>
\n
\n GeneDx <\/i>
\n <\/b>
\n class action lawsuit, please provide your information here:<\/b>\n <\/p>\n

\n
\n https:\/\/www.rgrdlaw.com\/cases-genedx-holdings-corp-class-action-lawsuit-wgs.html<\/b>
\n <\/a>\n <\/p>\n

\n You can also contact attorneys <\/b>
\n
\n Ken Dolitsky<\/b>
\n <\/a>
\n or <\/b>
\n
\n Michael Albert<\/b>
\n <\/a>
\n of Robbins Geller by calling 800\/851-7783 or via e-mail at <\/b>
\n
\n info@rgrdlaw.com<\/b>
\n <\/a>
\n .<\/b>\n <\/p>\n

\n CASE ALLEGATIONS<\/b>: GeneDx is a genomics company that provides genetic testing services.\u00a0 On April 16, 2025, GeneDx announced an agreement to acquire Fabric Genomics.\u00a0 Fabric Genomics is a firm focused on AI-driven genomic interpretation.<\/p>\n

The GeneDx <\/i>class action lawsuit alleges<\/span> that defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose significant problems in Fabric Genomic’s viability that would negatively impact GeneDx’s overall business and operations.<\/p>\n

On May 4, 2026, GeneDx announced its 2026 first quarter results, allegedly<\/span> revealing a drop in adjusted gross margin from 74% to 69%, reduced projected earnings from $540-$555 million to $475-$490 million, and a $31.3 million impairment loss directly attributable to Fabric Genomics.\u00a0 On this news, the price of GeneDx stock dropped over 49%, according to the complaint.\u00a0<\/p>\n

\n THE LEAD PLAINTIFF PROCESS<\/b>: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased GeneDx common stock during the Class Period to seek appointment as lead plaintiff in the GeneDx <\/i>class action lawsuit.\u00a0 A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.\u00a0 A lead plaintiff acts on behalf of all other class members in directing the GeneDx <\/i>class action lawsuit.\u00a0 The lead plaintiff can select a law firm of its choice to litigate the GeneDx <\/i>class action lawsuit.\u00a0 An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the GeneDx <\/i>class action lawsuit.<\/p>\n

\n ABOUT ROBBINS GELLER: <\/b>Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud<\/span> and shareholder rights litigation.\u00a0 Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025.\u00a0 This marks our fourth #1 ranking in the past five years.\u00a0 And in those five years alone, Robbins Geller recovered $8.4 billion for investors \u2013 $3.4 billion more than any other law firm.\u00a0 With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever \u2013 $7.2 billion \u2013 in In re Enron Corp. Sec. Litig.<\/i>\u00a0 Please visit the following page for more information:<\/p>\n

\n
\n https:\/\/www.rgrdlaw.com\/services-litigation-securities-fraud<\/span>.html<\/b>
\n <\/a>\n <\/p>\n

Past results do not guarantee future outcomes.\u00a0<\/p>\n

Services may be performed by attorneys in any of our offices.\u00a0<\/p>\n

Contact:<\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Robbins Geller Rudman & Dowd LLP<\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Ken Dolitsky<\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Michael Albert<\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0655 W. Broadway, Suite 1900, San Diego, CA 92101<\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0800\/851-7783<\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0info@rgrdlaw.com<\/b><\/a><\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-302797738.html<\/a><\/p>\n

SOURCE Robbins Geller Rudman & Dowd LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire SAN DIEGO, June 15, 2026 \/PRNewswire\/ —\u00a0Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the “Class Period”), have until August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit.\u00a0 Captioned Basma v. GeneDx Holdings Corp., No. 26-cv-00880 (D. Conn.), the GeneDx class action lawsuit charges GeneDx as well as certain of GeneDx’s top executive officers with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the GeneDx class action lawsuit, please provide your information here: https:\/\/www.rgrdlaw.com\/cases-genedx-holdings-corp-class-action-lawsuit-wgs.html You can also contact attorneys … <\/p>\n

Continue reading “WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-972125","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nWGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN DIEGO, June 15, 2026 \/PRNewswire\/ —\u00a0Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the “Class Period”), have until August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit.\u00a0 Captioned Basma v. GeneDx Holdings Corp., No. 26-cv-00880 (D. Conn.), the GeneDx class action lawsuit charges GeneDx as well as certain of GeneDx’s top executive officers with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the GeneDx class action lawsuit, please provide your information here: https:\/\/www.rgrdlaw.com\/cases-genedx-holdings-corp-class-action-lawsuit-wgs.html You can also contact attorneys … Continue reading "WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-15T15:07:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mmx.prnewswire.com\/media\/MS675308\/robbins-geller-rudman-and-dowd-llp-logo-v2_Logo.jpg?id=OA2696498\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\",\"datePublished\":\"2026-06-15T15:07:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/\"},\"wordCount\":591,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS675308\\\/robbins-geller-rudman-and-dowd-llp-logo-v2_Logo.jpg?id=OA2696498\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/\",\"name\":\"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS675308\\\/robbins-geller-rudman-and-dowd-llp-logo-v2_Logo.jpg?id=OA2696498\",\"datePublished\":\"2026-06-15T15:07:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS675308\\\/robbins-geller-rudman-and-dowd-llp-logo-v2_Logo.jpg?id=OA2696498\",\"contentUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS675308\\\/robbins-geller-rudman-and-dowd-llp-logo-v2_Logo.jpg?id=OA2696498\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/","og_locale":"en_US","og_type":"article","og_title":"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Market Newsdesk","og_description":"PR Newswire SAN DIEGO, June 15, 2026 \/PRNewswire\/ —\u00a0Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the “Class Period”), have until August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit.\u00a0 Captioned Basma v. GeneDx Holdings Corp., No. 26-cv-00880 (D. Conn.), the GeneDx class action lawsuit charges GeneDx as well as certain of GeneDx’s top executive officers with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the GeneDx class action lawsuit, please provide your information here: https:\/\/www.rgrdlaw.com\/cases-genedx-holdings-corp-class-action-lawsuit-wgs.html You can also contact attorneys … Continue reading \"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-15T15:07:06+00:00","og_image":[{"url":"https:\/\/mmx.prnewswire.com\/media\/MS675308\/robbins-geller-rudman-and-dowd-llp-logo-v2_Logo.jpg?id=OA2696498","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit","datePublished":"2026-06-15T15:07:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/"},"wordCount":591,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS675308\/robbins-geller-rudman-and-dowd-llp-logo-v2_Logo.jpg?id=OA2696498","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/","name":"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS675308\/robbins-geller-rudman-and-dowd-llp-logo-v2_Logo.jpg?id=OA2696498","datePublished":"2026-06-15T15:07:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#primaryimage","url":"https:\/\/mmx.prnewswire.com\/media\/MS675308\/robbins-geller-rudman-and-dowd-llp-logo-v2_Logo.jpg?id=OA2696498","contentUrl":"https:\/\/mmx.prnewswire.com\/media\/MS675308\/robbins-geller-rudman-and-dowd-llp-logo-v2_Logo.jpg?id=OA2696498"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/972125","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=972125"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/972125\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=972125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=972125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=972125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}